[Federal Register Volume 77, Number 109 (Wednesday, June 6, 2012)]
[Notices]
[Pages 33467-33468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-13688]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-12-0571]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to Kimberly S. Lane, at CDC, 1600 Clifton Road, MS D-74, 
Atlanta, GA 30333 or send an email to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Minimum Data Elements (MDEs) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) (OMB No. 0920-0571, exp. 11/
30/2012)--Extension--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Many cancer-related deaths in women could be avoided by increased 
utilization of appropriate screening and early detection tests for 
breast and cervical cancer. Mammography is extremely valuable as an 
early detection tool because it can detect breast cancer well before 
the woman can feel the lump, when the cancer is still in an early and 
more treatable stage. Similarly, a substantial proportion of cervical 
cancer-related deaths could be prevented through the detection and 
treatment of precancerous lesions. The Papanicolaou (Pap) test is the 
primary method of detecting both precancerous cervical lesions as well 
as invasive cervical cancer. Mammography and Pap tests are underused by 
women who have no source or no regular source of health care and women 
without health insurance.
    Despite the availability and increased use of effective screening 
and early detection tests for breast and cervical cancers, the American 
Cancer Society (ACS) estimates that 226,870 new cases of invasive 
breast cancer will be diagnosed among women in 2012, and 39,510 women 
will die of this disease. The ACS also estimates that 12,170 new cases 
of invasive cervical cancer will be diagnosed in 2012, and 4,220 women 
will die of this disease.
    The CDC's National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) provides screening services to underserved women 
through cooperative agreements with 50 States, the District of 
Columbia, 5 U.S. Territories, and 11 American Indian/Alaska Native 
tribal programs. The program was established in response to the Breast 
and Cervical Cancer Mortality Prevention Act of 1990. Screening 
services include clinical breast examinations, mammograms and Pap 
tests, as well as timely and adequate diagnostic testing for abnormal 
results, and referrals to treatment for cancers detected. NBCCEDP 
awardees collect patient-level screening and tracking data to manage 
the program and clinical services. A de-identified subset of data on 
patient demographics, screening tests and outcomes are reported by each 
awardee to CDC twice per year. Burden to respondents was significantly 
reduced in 2008 when the annual requirement to report infrastructure 
information (System for Technical Assistance Reporting, STAR), 
previously associated with collection of MDE information, was 
discontinued.
    CDC plans to request OMB approval to collect MDE information for an 
additional three years. CDC anticipates a reduction in the overall 
burden estimate due to a decrease in the number of awardees from 68 to 
67. There are no changes to the currently approved minimum data 
elements, electronic data collection procedures, or the estimated 
burden per response. Because NBCCEDP awardees already collect and 
aggregate data at the state, territory and tribal level, the additional 
burden of submitting data to CDC will be modest. CDC will use the 
information to monitor and evaluate NBCCEDP awardees; improve the 
availability and quality of screening and diagnostic services for 
underserved women; develop outreach strategies for women who are never 
or rarely screened for breast and cervical cancer, and report program 
results to Congress and other legislative authorities.
    There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent        (in hr)         (in hr)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees..............  Minimum Data                  67               2               4             536
                                 Elements.
----------------------------------------------------------------------------------------------------------------



[[Page 33468]]

Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the 
Associate Director for Science, Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2012-13688 Filed 6-5-12; 8:45 am]
BILLING CODE 4163-18-P